Poxel–LCF Rothschild: investment, 201007 financing round Series A totalling €16m incl lead investor EdRIP

	Period	2010-07-08
	Money taker	Poxel S.A. (Euronext: POXEL)
	Group	Poxel (Group)
	Money source	Edmond de Rothschild Investment Partners (EdRIP)
	Today	Andera Partners (FR)
	Group	Andera Partners (FR)
	Product	imeglimin
	Product 2	venture capital
	Person	Wisniewski, Raphaël (Andera Partners 202110 formerly LCF Rothschild at Edmond de Rothschild Investment Partners)

Record changed: 2018-04-15

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Poxel (Group)

[1] Poxel S.A.. (5/25/20). "Press Release: Poxel Announces Program Update and Preclinical Results on PXL770 for NASH Combinations and Other Metabolic Diseases". Lyon....
[2] Poxel S.A.. (5/25/20). "Press Release: Poxel Successfully Raises €17.7 Million in a Capital Increase [Not for US, AU, CA or JP]". Lyon....
[3] Poxel S.A.. (11/5/19). "Press Release: Poxel Obtains Additional Funding to Advance Pipeline Programs. Financing of up to EUR 30 Million through a Bond Loan with IPF Partners". Lyon....
[4] Artios Pharma Ltd.. (2/26/18). "Press Release: Artios Pharma Appoints Pierre Legault as Chairman of its Board of Directors". Cambridge....
[5] Poxel S.A.. (4/25/17). "Press Release: Poxel Announces Appointment of Anne Renevot as Chief Financial Officer". Lyon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]